Tuberculin purified protein derivative (coenbiotech)
结核菌素纯蛋白衍生物（成都可恩）
Report date: 2026/03/24 20:00:35
Base Information
Drug NameTuberculin purified protein derivative (coenbiotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSanofiChengdu Keen Biological Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChengdu Keen Biological Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksDrugBank